Telesis Bio Stock Gross Profit
Telesis Bio fundamentals help investors to digest information that contributes to Telesis Bio's financial success or failures. It also enables traders to predict the movement of Telesis Pink Sheet. The fundamental analysis module provides a way to measure Telesis Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Telesis Bio pink sheet.
Telesis |
Telesis Bio Company Gross Profit Analysis
Telesis Bio's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Telesis Bio Gross Profit | 15.6 M |
Most of Telesis Bio's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Telesis Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Telesis Bio reported 15.6 M of gross profit. This is 99.3% lower than that of the Health Care Equipment & Supplies sector and 98.36% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.94% higher than that of the company.
Telesis Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Telesis Bio's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Telesis Bio could also be used in its relative valuation, which is a method of valuing Telesis Bio by comparing valuation metrics of similar companies.Telesis Bio is currently under evaluation in gross profit category among its peers.
Telesis Fundamentals
| Return On Equity | -1.48 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (2.53) % | ||||
| Operating Margin | (6.76) % | ||||
| Current Valuation | 61.1 M | ||||
| Shares Outstanding | 1.77 M | ||||
| Shares Owned By Insiders | 37.90 % | ||||
| Shares Owned By Institutions | 32.97 % | ||||
| Number Of Shares Shorted | 29.7 K | ||||
| Price To Earning | 71.32 X | ||||
| Price To Book | 1.11 X | ||||
| Price To Sales | 0.29 X | ||||
| Revenue | 27.51 M | ||||
| Gross Profit | 15.6 M | ||||
| EBITDA | (31.05 M) | ||||
| Net Income | (47.72 M) | ||||
| Cash And Equivalents | 654.75 M | ||||
| Cash Per Share | 8.70 X | ||||
| Total Debt | 34.38 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | (11.59) X | ||||
| Cash Flow From Operations | (34.67 M) | ||||
| Short Ratio | 0.42 X | ||||
| Earnings Per Share | (30.42) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 101 | ||||
| Beta | 1.76 | ||||
| Market Capitalization | 5.73 M | ||||
| Total Asset | 70.41 M | ||||
| Retained Earnings | (161.47 M) | ||||
| Working Capital | 22.17 M | ||||
| Current Asset | 3.28 M | ||||
| Current Liabilities | 16.98 M | ||||
| Net Asset | 70.41 M |
Pair Trading with Telesis Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telesis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telesis Bio will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Marcus Millichap could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Marcus Millichap when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Marcus Millichap - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Marcus Millichap to buy it.
The correlation of Marcus Millichap is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Marcus Millichap moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Marcus Millichap moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Marcus Millichap can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |